Idorsia Ltd. is a biopharmaceutical company, which engages in the discovery, development, and commercialization of medicines for medical needs. It operates through the following geographical segments: Switzerland, United States, Japan, and Rest of World. The was founded on March 3, 2017 and is headquartered in Allschwil, Switzerland.